Advertisement

Papillary Thyroid Carcinoma with Central Lymph Node Metastases

  • Yasemin Giles Şenyürek
  • İsmail Cem Sormaz
Chapter

Abstract

Lymph nodal involvement in papillary thyroid carcinoma (PTC) is very common. Preoperative neck ultrasonography (USG) allows for the early detection of nonpalpable cervical lymph node metastasis prior to thyroidectomy in patients with FNAB-proven or suspected thyroid cancer. In patients with clinically involved central nodes, therapeutic central compartment (level VI) neck dissection should be performed. Lateral neck dissection performed for macroscopic PTC metastases should be the selective neck dissection of levels IIa, III, IV, and Vb. We present a 38-year-old female patient of unilateral PTC with central and ipsilateral lateral lymph node metastasis who underwent total thyroidectomy and bilateral central and ipsilateral lateral lymph node dissection followed by radioactive iodine ablation (RAI) treatment. Postoperative RAI adjuvant therapy should be considered in ATA intermediate-/high-risk level patients. In PTC patients, no biochemical, clinical, or radiological evidence of tumor during the follow-up after total thyroidectomy and RAI treatment is defined as excellent response to treatment. The rate of recurrence ranges between 1 and 4% in patients with excellent response. In intermediate-risk patients who are subsequently reclassified into excellent response category, non-stimulated thyroglobulin assays and neck USG at 12–24-month intervals are considered to be appropriate in the follow-up.

Keywords

Papillary thyroid carcinoma Central lymph node metastases Lymph node dissection 

References

  1. 1.
    Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov YE, et al. American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid. 2016;26:1–133.  https://doi.org/10.1089/thy.2015.0020.CrossRefPubMedPubMedCentralGoogle Scholar
  2. 2.
    Gharib H, Papini E. Thyroid nodules: clinical importance, assessment, and treatment. Endocrinol Metab Clin N Am. 2007;36:707–35.  https://doi.org/10.1016/j.ecl.2007.04.009.CrossRefGoogle Scholar
  3. 3.
    Lew IJ, Solorzano CC. Use of ultrasound in the management of thyroid cancer. Oncologist. 2010;15:253–8.  https://doi.org/10.1634/theoncologist.2009-0324.CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    Jabiev AA, Ikeda MH, Reis IM, Solorzano CC, Lew JI. Surgeon-performed ultrasound can predict differentiated thyroid cancer in patients with solitary thyroid nodules. Ann Surg Oncol. 2009;16:3140–5.  https://doi.org/10.1245/s10434-009-0652-9.CrossRefPubMedGoogle Scholar
  5. 5.
    Sherman SI. Thyroid carcinoma. Lancet. 2003;361:501–11.CrossRefGoogle Scholar
  6. 6.
    Trimboli P, Ulisse S, Graziano FM, Marzullo A, Ruggieri M, Calvanese A, et al. Trend in thyroid carcinoma size, age at diagnosis and histology in a retrospective study of 500 cases diagnosed over 20 years. Thyroid. 2006;16:1151–5.  https://doi.org/10.1089/thy.2006.16.1151.CrossRefPubMedGoogle Scholar
  7. 7.
    Mirallié E, Visset J, Sagan C, Hamy A, Le Bodic MF, Paineau J. Localization of cervical node metastasis of papillary thyroid carcinoma. World J Surg. 1999;23:970–4.CrossRefGoogle Scholar
  8. 8.
    Machens A, Hinze R, Thomusch O, Dralle H. Pattern of nodal metastasis for primary and reoperative thyroid cancer. World J Surg. 2002;26:22–8.  https://doi.org/10.1007/s00268-001-0176-3.CrossRefPubMedGoogle Scholar
  9. 9.
    Kouvaraki MA, Shapiro SE, Fornage BD, Edeiken-Monro BS, Sherman SI, Vassilopoulou-Sellin R, et al. Role of preoperative ultrasonography in the surgical management of patients with thyroid cancer. Surgery. 2003;134:946–55.  https://doi.org/10.1016/S0039-6060(03)00424-0.CrossRefPubMedGoogle Scholar
  10. 10.
    Stulak JM, Grant CS, Farley DR, Thompson GB, van Heerden JA, Hay ID, et al. Value of preoperative ultrasonography in the surgical management of initial and reoperative papillary thyroid cancer. Arch Surg. 2006;141:489–96.  https://doi.org/10.1001/archsurg.141.5.489.CrossRefPubMedGoogle Scholar
  11. 11.
    Pak K, Suh S, Hong H, Kim SJ, Kim IJ, Kim EE, et al. Diagnostic values of thyroglobulin measurement in fine-needle aspiration of lymph nodes in patients with thyroid cancer. Endocrine. 2015;49:70–7.  https://doi.org/10.1007/s12020-014-0410-z.CrossRefPubMedGoogle Scholar
  12. 12.
    Lee KE, Chung Y, Kang E, Koo do H, Kim KH, Kim SW, et al. Ipsilateral and contralateral central lymph node metastasis in papillary thyroid cancer: patterns and predictive factors of nodal metastasis. Head Neck. 2013;35:672–6.  https://doi.org/10.1002/hed.23016.CrossRefPubMedGoogle Scholar
  13. 13.
    Roh JL, Kim JM, Park CI. Central lymph node metastasis of unilateral papillary thyroid carcinoma: patterns and factors predictive of nodal metastasis, morbidity, and recurrence. Ann Surg Oncol. 2011;18:2245–50.  https://doi.org/10.1245/s10434-011-1600-z.CrossRefPubMedGoogle Scholar
  14. 14.
    Ito Y, Fukushima M, Higashiyama H, Kihara M, Takamura Y, Kobayashi K, et al. Tumor size is the strongest predictor of microscopic lymph node metastasis and lymph node recurrence of N0 papillary thyroid carcinoma. Endocr J. 2013;60:113–7.CrossRefGoogle Scholar
  15. 15.
    Roh JL, Kim JM, Park CI. Lateral cervical lymph node metastases from papillary thyroid carcinoma: pattern of nodal metastases and optimal strategy for neck dissection. Ann Surg Oncol. 2008;15:1177–82.  https://doi.org/10.1245/s10434-008-9813-5.CrossRefPubMedGoogle Scholar
  16. 16.
    Zhao Q, Ming J, Liu C, Shi L, Xu X, Nie X, et al. Multifocality and total tumor diameter predict central neck lymph node metastases in papillary thyroid microcarcinoma. Ann Surg Oncol. 2013;20:746–52.  https://doi.org/10.1245/s10434-012-2654-2.CrossRefPubMedGoogle Scholar
  17. 17.
    So YK, Son YI, Park JY, Baek CH, Jeong HS, Chung MK. Preoperative BRAF mutation has different predictive values for lymph node metastasis according to tumor size. Otolaryngol Head Neck Surg. 2011;145:422–7.  https://doi.org/10.1177/0194599811404649.CrossRefPubMedGoogle Scholar
  18. 18.
    Carty SE, Cooper DS, Doherty GM, Duh QY, Kloos RT, Mandel SJ, American Thyroid Association Surgery Working Group, American Association of Endocrine Surgeons, American Academy of Otolaryngology-Head and Neck Surgery, American Head and Neck Society, et al. Consensus statement on the terminology and classification of central neck dissection for thyroid cancer. Thyroid. 2009;19:1153–8.  https://doi.org/10.1089/thy.2009.0159.CrossRefPubMedGoogle Scholar
  19. 19.
    Koo BS, Choi EC, Yoon YH, Kim DH, Kim EH, Lim YC. Predictive factors for ipsilateral or contralateral central lymph node metastasis in unilateral papillary thyroid carcinoma. Ann Surg. 2009;249:840–4.  https://doi.org/10.1097/SLA.0b013e3181a40919.CrossRefPubMedGoogle Scholar
  20. 20.
    Koo BS, Choi EC, Park YH, Kim EH, Lim YC. Occult contralateral central lymph node metastases in papillary thyroid carcinoma with unilateral lymph node metastasis in the lateral neck. J Am Coll Surg. 2010;210:895–900.  https://doi.org/10.1016/j.jamcollsurg.2010.01.037.CrossRefPubMedGoogle Scholar
  21. 21.
    Park JH, Lee YS, Kim BW, Chang HS, Park CS. Skip lateral neck node metastases in papillary thyroid carcinoma. World J Surg. 2012;36:743–7.  https://doi.org/10.1007/s00268-012-1476-5.CrossRefPubMedGoogle Scholar
  22. 22.
    Kang BC, Roh JL, Lee JH, Cho KJ, Gong G, Choi SH, et al. Candidates for limited lateral neck dissection among patients with metastatic papillary thyroid carcinoma. World J Surg. 2014;38:863–71.  https://doi.org/10.1007/s00268-013-2361-6.CrossRefPubMedGoogle Scholar
  23. 23.
    Chereau N, Buffet C, Tresallet C, Tissier F, Leenhardt L, Menegaux F. Recurrence of papillary thyroid carcinoma with lateral cervical node metastases: predictive factors and operative management. Surgery. 2016;159:755–62.  https://doi.org/10.1016/j.surg.2015.08.033.CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2019

Authors and Affiliations

  • Yasemin Giles Şenyürek
    • 1
  • İsmail Cem Sormaz
    • 1
  1. 1.Division of Endocrine SurgeryIstanbul University Istanbul Medical FacultyIstanbulTurkey

Personalised recommendations